Short description:
Contact us to add description: recruit@workinbiotech.com
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Obsidian Therapeutics is developing tumor infiltrating lymphocyte (TIL) therapies for patients with intractable diseases. Conventional TIL therapies have had some success for cancer patients but are still limited by toxicity concerns caused by concomitant IL2 therapy. Using their proprietary cytoDRIVE platform, Obsidian is engineering cytoTIL therapies to express therapeutic proteins that enhance anti-tumor activity and reduce toxicity. Obsidian’s lead program, cytoTIL15, has been engineered to eliminate the need for concomitant IL2 therapy improving the magnitude and duration of response. cytoTIL15 will enter clinical trials for patients with metastatic melanoma.
Jobs:
Senior Manager, Quality Assurance (Cell Therapy) Cambridge, MA|7 days ago
Scientist/Associate Scientist, Process Development... Cambridge, MA|9 days ago
Senior Research Associate, Process Development (Ce... Cambridge, MA|9 days ago
General Interest Application - Obsidian Talent Com... Cambridge, MA|100+ days ago